This excerpt taken from the TPTX 8-K filed Oct 10, 2006.
THIS DEVELOPMENT AND LICENSE AGREEMENT (the “Agreement”) is entered into as of April 21, 2003 (the “Effective Date”), by and between NEUROGENETICS, INC. (“Neurogenetics”), a corporation organized and existing under the laws of the State of Delaware, having its principal place of business at 11805 North Torrey Pines Road, Suite 300, La Jolla, California 92037, and ELI LILLY AND COMPANY (“Lilly”), a corporation organized and existing under the laws of the State of Indiana, having its principal place of business at Lilly Corporate Center, Indianapolis, Indiana 46285. Neurogenetics and Lilly are sometimes referred to herein individually as a “Party” and collectively as “Parties.”  The Parties agree as follows:


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki